Jessica Hagen

New York-based Somethings will use the funds to scale its mobile app that connects teens and young adults with trained peer mentors.

The partnership will allow Mira's hormone test results to be compared with Oura Ring data on sleep, temperature and readiness, enabling trend tracking.

The California-based company will use the funds to expand its healthcare advocate network and platform, partnerships with payers and providers and for clinical research.

Debra Beauregard, director of medical intelligence and innovation at San Diego-based Rady Children's Health, joins MobiHealthNews to discuss partnering with digital health companies.

The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.

The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.

A federal jury found that Medtronic, which plans to appeal the ruling, unlawfully monopolized the bipolar surgical device market through anticompetitive bundling and exclusive-deal practices that harmed rival Applied Medical.

Dr. Guido Giunti highlights his upcoming HIMSS26 talk that will encourage attendees to ask sharper questions about AI and feel empowered to drive change at any level of healthcare.

The company has filed to list its Class A shares as it looks to scale its AI- and blockchain-enabled telehealth platform after U.S. expansion and private financing.

Sergio Calvo, general manager of theranostics at GE HealthCare, joins MobiHealthNews to discuss how combining molecular imaging and targeted therapy is personalizing cancer care.